Rhabdomyosarcoma: Biology and treatment

Pediatric Clinics of North America

Volumn 44, Issue 4, 1997, Pages 953-972

  Pappo, A S ^a   Shapiro, D N ^a   Crist, W M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; NEUROBLASTOMA; PROGNOSIS; REVIEW; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; TUMOR LOCALIZATION; UNITED STATES;

EID: 0030880057     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70539-3     Document Type: Article

References (59)

1. M. Carli R. Pinkerton E. Frascella Intensive chemotherapy for metastatic sarcoma in children. SIOP European Intergroup Study MMT89 [abstract] Proc Am Soc Clin Oncol 12 1993 410
2. A.O. Cavazzana D. Schmidt V. Ninfo Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma Am J Surg Pathol 16 1992 229 235
3. W. Crist E.A. Gehan A.H. Ragab The Intergroup Rhabdomyosarcoma Study-III J Clin Oncol 13 1995 610 630
4. W.M. Crist M.S. Beltangady E. Gehan Prognosis in children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II J Clin Oncol 8 1990 443 452
5. W.M. Crist L.E. Kun Common solid tumors of childhood N Engl J Med 324 1991 461 471
6. R.J. Davis C.M. D'Cruz M.A. Lovell Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma Cancer Res 54 1994 2869 2872
7. O. Delattre J. Zucman T. Melot The Ewing family of tumors: A subgroup of small-round-cell tumors defined by specific chimeric transcripts N Engl J Med 331 1994 294 299
8. P. Dias P. Kumar H.B. Marsden N- myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS Int J Cancer 45 1990 593 596
9. P. Dias D.M. Parham D.N. Shapiro Myogenic regulatory protein ( Myo D1) expression in childhood solid tumors; diagnostic utility in rhabdomyosarcoma Am J Path 137 1990 1283 1291
10. S.S. Donaldson The value of adjuvant chemotherapy in the management of sarcomas in children Cancer 55 1985 2184 2197
11. S.S. Donaldson L. Asmar J. Breneman Hyperfractionated radiation in children with rhabdomyosarcoma: Results of an Intergroup Rhabdomyosarcoma pilot study Int J Radiol Oncol Biol Phys 32 1995 903 911
12. J.R. Downing A. Khanderkar S.A. Shurtleff A multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma versus Ewing's sarcoma Am J Pathol 146 1995 626 634
13. O.M. El-Badry C. Minniti E.C. Kohn Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors Cell Growth Differ 1 1990 325 331
14. C.A. Felix C.C. Kappel T. Mitsudomi Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma Cancer Res 52 1992 2247
15. F. Flamant H. Hill The improvement in survival associated with combined chemotherapy in childhood rhabdomyosarcoma: A historical comparison of 345 patients in the same center Cancer 53 1984 2417 2421
16. F. Flamant C. Rodary A. Rey Assessing the benefit of primary chemotherapy in the treatment of rhabdomyosarcoma in children: Report from the International Society of Pediatric Oncology: RMS 84 study [abstract] Proc Am Soc Clin Oncol 10 1991 309
17. F. Flamant C. Rodary P.A. Voute J. Otten Primary chemotherapy in the treatment of rhabdomyosarcoma in children: Trial of the International Society of Pediatric Oncology (SIOP) preliminary results Radiother Oncol 3 1985 227 236
18. R.M. Heyn R. Holland J.W.A. Newton The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children Cancer 34 1974 2128 2142
19. R. Heyn F. Khan L. Ensign Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on the Intergroup Rhabdomyosarcoma Study III: An interim report Med Pediatr Oncol 23 1994 93 106
20. R. Heyn A. Ragab R.B. Raney Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study Cancer 57 1986 1738 1743
21. R. Heyn R.B. Raney D.M. Hays Late effects of therapy in patients with paratesticular rhabdomyosarcoma J Clin Oncol 10 1992 614 623
22. R.C. Horn H.T. Enterline Rhabdomyosarcoma: A clinicopathological study and classification of 39 cases Cancer 11 1958 181 199
23. H. Hosoi T. Sugimoto Y. Hayashi Differential expression of myogenic regulatory genes, Myo D1 and myogenin, in human rhabdomyosarcoma sublines Int J Cancer 50 1992 977 983
24. P.J. Houghton D.N. Shapiro J.A. Houghton Rhabdomyosarcoma: From the laboratory to the clinic Pediatr Clin North Am 38 1991 349 364
25. W. Johnson J. Jurand R. Hiramoto Immunohistologic studies of tumors containing myosin Am J Pathol 47 1965 1139 1155
26. K.M. Kelly R.B. Womer P. Sorensen Common and variant gene fusions predict clinical phenotype in rhabdomyosarcoma (RMS) [abstract] Proc Am Soc Clin Oncol 15 1996 462
27. J.E. Kingston T.J. McElwain J.S. Malpas Childhood rhabdomyosarcoma: Experience of the Children's Solid Tumour Group Br J Cancer 48 1983 195 207
28. R. Kodet W.A. Newton A.B. Hamoudi Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features: A report of the Intergroup Rhabdomyosarcoma Study Am J Surg Pathol 17 1993 443 453
29. E. Koscielniak H. Jurgens K. Winkler Treatment of soft tissue sarcoma in childhood and adolescence Cancer 70 1992 2557 2567
30. W.J. Lawrence E.A. Gehan D.M. Hays Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study (IRS-II) J Clin Oncol 5 1987 46 54
31. F.P. Li Fraumeni Jr J.J. Mulvihill A cancer family syndrome in twenty-four kindreds Cancer Res 48 1988 5358 5362
32. H.M. Maurer M. Beltangady E.A. Gehan The Intergroup Rhabdomyosarcoma Study-I: A final report Cancer 61 1988 209 220
33. H.M. Maurer E.A. Gehan M. Beltangady The Intergroup Rhabdomyosarcoma Study-II Cancer 71 1993 1904 1922
34. W.A. Newton E.A. Gehan B.L. Webber Classification of rhabdomyosarcomas and related sarcomas: Pathologic aspects and proposal for a new classification—an Intergroup rhabdomyosarcoma study Cancer 76 1995 1073 1084
35. W.A. Newton E.H. Soule A.B. Hamoudi Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: Clinicopathologic correlation J Clin Oncol 6 1988 67 75
36. F.K. Niggli J.E. Powell S.E. Parkes DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: Their value as prognostic indicators Br J Cancer 69 1994 1106 1110
37. A. Pappo E. Etcubanas V. Santana A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma Cancer 71 1993 2119 2125
38. A.S. Pappo W.M. Crist J. Kuttesch Tumor cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma J Clin Oncol 11 1993 1901 1905
39. P.M. Potter D. Shapiro P. Dias P. Houghton Ribozyme-mediated cleavage of a fusion transcript specifically expressed in alveolar rhabdomyosarcoma Proc Ann Meeting Am Assoc Cancer Res 35 1994 530
40. C.B. Pratt H.O. Hustu I.D. Fleming D. Pinkel Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy Cancer Res 32 1972 606 610
41. S. Rainier L.A. Johnson C.J. Dobry Relaxation of imprinted genes in human cancer Nature 362 1993 747 749
42. R.B. Raney D.M. Hays M. Tefft T.J. Triche Rhabdomyosarcoma and the undifferentiated sarcomas P.A. Pizzo D.G. Poplack Principles and Practice of Pediatric Oncology 1993 JB Lippincott Philadelphia 769 794
43. B. Raney R. Heyn D. Hays Sequelae of treatment in 109 patients followed for five to fifteen years after diagnosis of sarcoma of the bladder and prostate: A Report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee Cancer 71 1993 2387 2394
44. R.B. Raney M. Tefft W.A. Newton Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study Cancer 59 1987 147 155
45. C. Rodary E. Gehan F. Flamant Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: A report from the International Rhabdomyosarcoma Workshop Med Pediatr Oncol 19 1991 89 95
46. C. Rodary A. Rey D. Olive Prognostic factors in 281 children with non-metastatic rhabdomyosarcoma at diagnosis Med Pediatr Oncol 16 1988 71 77
47. H. Scrable D. Witte H. Shimada Molecular differential pathology of rhabdomyosarcoma Genes Chromosomes and Cancer 1 1989 23 35
48. D.N. Shapiro B.G. Jones L.H. Shapiro Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma J Clin Invest 94 1994 1235 1242
49. D.N. Shapiro J.E. Sublett B. Li Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma Cancer Res 53 1993 5108 5112
50. M.C.G. Stevens O. Oberlin A. Rey M. Praquin Non metastatic rhabdomyosarcoma: Experience from the SIOP MMT 89 study Med Pediatr Oncol 23 1994 171
51. S.J. Tapscott H. Weintraub MyoD and the regulation of myogenesis by helix-loop-helix proteins J Clin Invest 87 1991 1133 1138
52. M. Tefft C. Fernandez M. Donaldson Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children: A report of the Intergroup Rhabdomyosarcoma Study (IRS) Cancer 42 1978 253 258
53. P.N. Tonin H. Scrable H. Shimada W.K. Cavenee Muscle-specific gene expression in rhabdomyosarcomas, and stages of human fetal skeletal muscle development Cancer Res 51 1991 5100 5106
54. J. Treuner E. Koscielniak M. Keim Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas Cancer Chemother Pharmacol 24 1989 48 50
55. M. Tsokos The diagnosis and classification of childhood rhabdomyosarcoma Sem Diag Pathol 11 1994 26 38
56. M. Tsokos B.L. Webber D.M. Parham Rhabdomyosarcoma: A new classification scheme related to prognosis Arch Pathol Lab Med 116 1992 847 855
57. C.O. Weber Anatomische untersuchung einer hypertrophische zunge nebst bemerkungen ueber die neubildung quergestreifter muskelfasern, virchow Arch Pathol Anat 7 1954 115 121
58. M.D. Wharam J.R. Anderson F. Laurie Failure-free survival for orbit rhabdomyosarcoma patients on Intergroup Rhabdomyosarcoma Study IV (IRS-IV) is improved compared to IRS-III [abstract] Proc Am Soc Clin Oncol 16 1997 518
59. J.R. Wilbur Combination chemotherapy for embryonal rhabdomyosarcoma Cancer Chemother Rep 58 1974 281 284